Modeling Target/Receptor Axis for T Cell Therapy: Scalable Personalised TCR-T

Time: 4:15 pm
day: Conference Day One

Details:

  • Development of engineered cancer cells for precise and systematic models to qualitatively map HLA-peptide targets
  • Development of engineered T-cells for systematic determination of HLA-peptide target specific TCR activity
  • Standardization of cell-based analysis platforms facilitating personalised treatment strategies

Speakers:

Hugh Salter
Hugh Salter